A Randomized Comparative Clinical Study To Evaluate The Efficacy Of Keshkusum An Oil based Scalp Serum As Keshya Therapy In Reducing Khalitya (Excessive Hair Fall) Among Healthy Individuals.
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
研究概览
简要总结
| Title |
A Randomized Comparative Clinical Study To Evaluate The Efficacy Of **“**Keshkusum” -An Oil based Scalp SerumAs KeshyaTherapy in Reducing Khalitya (Excessive Hair Fall) Among Healthy Individuals.
|PG Scholar
Dr. Trisha S. Suvarna
|Guide
Dr. Pratik Patil
|Study site
Padmashree Dr D Y Patil Deemed to be University, School of Ayurveda,
Nerul, Navi Mumbai-400706.
|Study Design
Randomised, open labelled, double arm , comparative prospective clinical study.
|Study duration
60 days
|Aim
To evaluate the clinical efficacy of “Keshkusum” -An Oil based Scalp Serum as a topical Keshya therapy in reducing Khalitya (Excessive Hair fall) among healthy individuals .
|Objectives
- To develop and standardize **“**Keshkusum” -An Oil based Scalp Serum
- To evaluate the changes in reduction of hair fall.
- To provide clinical evidences on how classical Ayurvedic herbs and practices can be reformulated into modern, user-friendly formats like serums.
- To assess patient satisfaction and compliance of the oil-based serum.
|Population to be studied
Healthy individuals with hair fall will be screened from Swasthya rakshanOPD No-6, Kayachikitsa OPD No-1 and Screening Camps conducted by Padmashree D.Y Patil University School of Ayurveda, Nerul, Navi Mumbai.
|Sample size
GROUP A -35 participants (considering 20% dropout rate)
GROUP B -35 participants (considering 20% dropout rate)
|Inclusion criteria
1. Individuals aged 18 to 45 years .
2. Both males and females with self-reported excessive hair fall (with the females having 40-50 counts of hair fall and male having 25-30 counts of hair fall) as determined from 60 second hair combing method at screening visit.
3. Good general health with no diagnosed systemic or dermatological illness.
4. Willingness to provide informed written consent and comply with study protocol.
|Exclusion criteria
1.Pregnant women and Lactating mothers.
2.Any systemic illness (e.g., thyroid dysfunction, anemia , PCOS) and treatments (e.g. chemotherapy) that could cause secondary hair fall.
- Use of topical or oral hair loss treatments in the last 3 months
4.Individuals with diagnosed alopecia areata, androgenic alopecia, or scalp infections
|Efficacy parameters
1. Khalitya signs and symptoms by VAS Scale
2. Hair Pull test.
3. 60 second Hair comb test
4. Dermatoscope
5. HairDex Quality of Life Questionnaire
|Safety parameters
Adverse events recording.
|Efficacy & Safety parameters Assessment Schedule
1. Khalitya signs and symptoms by VAS Scale- V1,V2,V3,V4.V5
2. Hair Pull test- V1,V2,V3,V4,V5
3. 60 second Hair comb test- V1,V2,V3,V4,V5
4. Dermatoscope- V1,V5
5. Physical examination: will be done on V1, V2, V3, V4, V5
6. HairDex Quality of Life Questionnaire V1 and V5
7. Questionnaire after completion of treatment-V5
|Statistical Analysis
Inter-Group Comparison:
Mann-Whitney U test (for non-parametric data), Unpaired t test (parametric data)
| S.NO. |
GROUPS
GROUP A
GROUP B
|1.
PROCEDURE
Keshkusum -An Oil Based Scalp Serum + Bhringaraj Ghanavati
Bhringraj Ghanavati
|2.
ROUTE
Oral +Topical
Oral
|3.
DOSAGE
Keshkusum - Q.S
*Bhringraj Ghanavati -*1 tablet (250 mg) thrice daily
*Bhringraj Ghanavati -*1 tablet (250 mg) thrice daily
|4.
TIME OF ADMINISTRATION
Keshkusum – once at night in sufficient quantity.
Bhringraj Ghanavati-Morning, Afternoon and Night after food.
*Bhringraj Ghanavati –*Morning, Afternoon and Nightafter food.
|5.
DURATION
60 days
60 days
|6.
NO. OF PARTICIPANTS
30
30
|7.
VISITS/ FOLLOW UP
15th day ,
30th day,
45th day,
60th day
15th day ,
30th day,
45th day,
60th day
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 45.00 Year(s)(—)
- 性别
- All
入选标准
- •1.Individuals aged 18 to 45 years.
- •2.Both males and females with self-reported excessive hair fall (with the females having 40-50 counts of hair fall and male having 25-30 counts of hair fall) as determined from 60 second hair combing method at screening visit.
- •3.Good general health with no diagnosed systemic or dermatological illness.
- •4.Willingness to provide informed written consent and comply with study protocol.
排除标准
- •1.Pregnant women and Lactating mothers.
- •2.Any systemic illness (e.g., thyroid dysfunction, anemia , PCOS) and treatments (e.g.chemotherapy) that could cause secondary hair fall.
- •3.Use of topical or oral hair loss treatments in the last 3 months.
- •4.Individuals with diagnosed alopecia areata, androgenic alopecia, or scalp infections.
研究者
Dr Trisha Surendra Suvarna
Padmashree Dr DY Patil Deemed To Be University, School Of Ayurveda.
